On May 17, 2020, Dr. Tali Gorfine notified Galmed Pharmaceuticals Ltd. that due to personal reasons she would need to reduce the scope of her activities, starting July 2020. This decision is not related to operations of the Company. The Company initiated a search for a new Chief Medical Officer who would be based in the United States, with a view to expanding the Company's presence in the United States. Dr. Gorfine intends to support the transition period as required and continue to support the Company's clinical activities.